Martell Christopher
SEC insider (Form 3/4/5 filer). CIK 0001873465. Director at Candel Therapeutics, Inc. (CADL). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in NEEDHAM, MA.
Companies Martell Christopher has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Director
Martell Christopher
CIK: 0001873465
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CADL
Candel Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 23, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32K shares- - Jun 25, 2025CADL
Candel Therapeutics, Inc.
AwardIndirect111.3K shares at avg. $4.67$520K - Jun 17, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
14.2K shares-
1-3 of 3 transactions